Develops, manufactures and markets a vaccine to eradicate fish
diseases, particularly for the KHV viral disease in the Common
Carp and Koi fish.
Employees: 5
Main Markets:
Fish Farms, Veterinars.
Overview
KOVAX LTD. was established in 2003 in order to develop,
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
manufacture and market a vaccine to eradicate fish diseases.
The company has Vaccine-manufacturing capabilities as well as a
high technology R&D department.
The KOVAX team is composed of talented individuals with complied
qualifications, each successful in substantial fields. Essential
for the project success: Science frontier, outstanding business
development and project management success.
KOVAX has acquired the patent for the KHV vaccine (For KOI and
Common Carp ) and the immune-based diagnostic kit from the Hebrew
University and the Israeli Ministry of Agriculture. The KHV
vaccine was developed by Professor Moshe Kotler.
KOVAX is the only company in the world that produces and markets
an efficient and safe vaccine against KHV disease.
Starting 2006 KOVAX R&D department is focusing on development -
"Novel vaccine methodology".
